Cannabichromenic acid synthase from cannabis sativa
US10364416B2 · kind B2 · utility
1Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2015 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | Jun 29, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y103/03
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Nucleic acid molecules from cannabis have been isolated and characterized and encode polypeptides having cannabichromenic acid synthase activity. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds. The polypeptides may be used in vivo or in vitro to produce cannabinoid compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.